10-QT Filing

Astrana Health, Inc. CIK: 1083446 Q1 2014

Filing Information

Form Type	10-QT
Accession Number	`0001144204-14-041793`
Period End Date	20140331
Filing Date	20140708
Fiscal Year	2014
Fiscal Period	Q1
XBRL Instance	ameh-20140331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 72 Income Statement 32 Cash Flow Statement 72 Stockholders Equity 10

Balance Sheet 72 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$6.83M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.45M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.18M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.09M	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Restricted cash	`RestrictedCashAndInvestmentsCurrent`	$20.00K	USD	Point-in-time
Restricted cash	`RestrictedCashAndInvestmentsCurrent`	$20.00K	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$1.51M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$1.51M	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Due from affiliates	`DueFromAffiliateCurrent`	$24.04K	USD	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	49.13M	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	46.95M	shares	Point-in-time
Due from affiliates	`DueFromAffiliateCurrent`	$1.60K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$53.54K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$42.20K	USD	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	49.13M	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	46.95M	shares	Point-in-time
Deferred financing costs, net, current	`DeferredFinanceCostsCurrentNet`	-	USD	Point-in-time
Deferred financing costs, net, current	`DeferredFinanceCostsCurrentNet`	$97.81K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$3.13M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$8.43M	USD	Point-in-time
Deferred financing costs, net, non-current	`DeferredFinanceCostsNoncurrentNet`	$366.29K	USD	Point-in-time
Deferred financing costs, net, non-current	`DeferredFinanceCostsNoncurrentNet`	$144.34K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$85.69K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$94.95K	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$62.43K	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$59.63K	USD	Point-in-time
Goodwill	`Goodwill`	$494.70K	USD	Point-in-time
Goodwill	`Goodwill`	$494.70K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$38.68K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$41.64K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$3.96M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$9.48M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$1.37M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$2.00M	USD	Point-in-time
Notes and lines of credit payable, net of discount - current portion	`NotesAndLinesOfCreditPayableCurrent`	$444.76K	USD	Point-in-time
Notes and lines of credit payable, net of discount - current portion	`NotesAndLinesOfCreditPayableCurrent`	$3.18M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.44M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.55M	USD	Point-in-time
Warrant liability	`DerivativeLiabilitiesNoncurrent`	$2.35M	USD	Point-in-time
Warrant liability	`DerivativeLiabilitiesNoncurrent`	-	USD	Point-in-time
Notes payable, net of discount - non-current portion	`LongTermNotesPayable`	-	USD	Point-in-time
Notes payable, net of discount - non-current portion	`LongTermNotesPayable`	$5.34M	USD	Point-in-time
Convertible notes payable, net	`ConvertibleLongTermNotesPayable`	$1.10M	USD	Point-in-time
Convertible notes payable, net	`ConvertibleLongTermNotesPayable`	$962.98K	USD	Point-in-time
Total liabilities	`Liabilities`	$5.65M	USD	Point-in-time
Total liabilities	`Liabilities`	$11.11M	USD	Point-in-time
Preferred stock, par value $0.001; 5,000,000 shares authorized; none issued	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.001; 5,000,000 shares authorized; none issued	`PreferredStockValue`	-	USD	Point-in-time
Common Stock, par value $0.001; 100,000,000 shares authorized, 49,134,519 and 46,952,469 shares issued and outstanding as of March 31, 2014 and January 31, 2014, respectively	`CommonStockValue`	$49.13K	USD	Point-in-time
Common Stock, par value $0.001; 100,000,000 shares authorized, 49,134,519 and 46,952,469 shares issued and outstanding as of March 31, 2014 and January 31, 2014, respectively	`CommonStockValue`	$46.95K	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapital`	$14.11M	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapital`	$15.08M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-16.35M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-15.58M	USD	Point-in-time
Stockholders' Deficit Attributable to Apollo Medical Holdings, Inc.	`StockholdersEquity`	$-1.43M	USD	Point-in-time
Stockholders' Deficit Attributable to Apollo Medical Holdings, Inc.	`StockholdersEquity`	$-1.22M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$-408.07K	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$-263.90K	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.69M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.62M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	`LiabilitiesAndStockholdersEquity`	$9.48M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	`LiabilitiesAndStockholdersEquity`	$3.96M	USD	Point-in-time

Income Statement 32 line items

Line Item	Tag	Value	Unit	Period
Net revenues	`Revenues`	$1.66M	USD	1 Quarter
Net revenues	`Revenues`	$2.34M	USD	1 Quarter
Cost of services	`CostOfServices`	$2.05M	USD	1 Quarter
Cost of services	`CostOfServices`	$1.18M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$826.87K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$531.12K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$4.51K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$5.76K	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$1.72M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$2.88M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-57.46K	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-547.03K	USD	1 Quarter
Interest expense	`InterestExpense`	$184.58K	USD	1 Quarter
Interest expense	`InterestExpense`	$86.11K	USD	1 Quarter
Other income	`OtherNonoperatingIncome`	$1.48K	USD	1 Quarter
Other income	`OtherNonoperatingIncome`	$28.82K	USD	1 Quarter
Total other expenses	`NonoperatingIncomeExpense`	$-84.64K	USD	1 Quarter
Total other expenses	`NonoperatingIncomeExpense`	$-155.76K	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-142.10K	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-702.79K	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$3.00K	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$7.82K	USD	1 Quarter
Net loss	`ProfitLoss`	$-710.61K	USD	1 Quarter
Net loss	`ProfitLoss`	$-145.10K	USD	1 Quarter
Net income attributable to non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$55.83K	USD	1 Quarter
Net income attributable to non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Net loss attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$-145.10K	USD	1 Quarter
Net loss attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$-766.44K	USD	1 Quarter
WEIGHTED AVERAGE SHARES OF COMMON STOCK OUTSTANDING - BASIC AND DILUTED	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	34.84M	shares	1 Quarter
WEIGHTED AVERAGE SHARES OF COMMON STOCK OUTSTANDING - BASIC AND DILUTED	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	47.18M	shares	1 Quarter
BASIC AND DILUTED NET LOSS PER SHARE	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	1 Quarter
BASIC AND DILUTED NET LOSS PER SHARE	`EarningsPerShareBasicAndDiluted`	-	USD	1 Quarter

Cash Flow Statement 72 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-710.61K	USD	1 Quarter
Net loss	`ProfitLoss`	$-145.10K	USD	1 Quarter
Gain on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$23.00K	USD	1 Quarter
Gain on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$4.51K	USD	1 Quarter
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$5.76K	USD	1 Quarter
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$60.19K	USD	1 Quarter
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$45.29K	USD	1 Quarter
Amortization of financing costs	`AdjustmentForAmortization`	$25.96K	USD	1 Quarter
Amortization of financing costs	`AdjustmentForAmortization`	$9.51K	USD	1 Quarter
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$15.17K	USD	1 Quarter
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$19.41K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-1.13K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$158.63K	USD	1 Quarter
Due from affiliates	`IncreaseDecreaseDueFromAffiliates`	$12.06K	USD	1 Quarter
Due from affiliates	`IncreaseDecreaseDueFromAffiliates`	$22.44K	USD	1 Quarter
Prepaid expenses and advances	`IncreaseDecreaseInPrepaidExpense`	$-12.39K	USD	1 Quarter
Prepaid expenses and advances	`IncreaseDecreaseInPrepaidExpense`	$-11.34K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	-	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$2.95K	USD	1 Quarter
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$626.31K	USD	1 Quarter
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$50.38K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-178.55K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-8.89K	USD	1 Quarter
Property and equipment acquired	`PaymentsToAcquirePropertyPlantAndEquipment`	$3.20K	USD	1 Quarter
Property and equipment acquired	`PaymentsToAcquirePropertyPlantAndEquipment`	$12.23K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-12.23K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-3.20K	USD	1 Quarter
Proceeds from notes and line of credit payable	`ProceedsFromNotesAndLineOfCreditPayable`	-	USD	1 Quarter
Proceeds from notes and line of credit payable	`ProceedsFromNotesAndLineOfCreditPayable`	$7.00M	USD	1 Quarter
Payment of line of credit payable	`RepaymentsOfLinesOfCredit`	$2.81M	USD	1 Quarter
Payment of line of credit payable	`RepaymentsOfLinesOfCredit`	-	USD	1 Quarter
Payment of medical clinic acquisition notes payable	`PaymentOfMedicalClinicAcquisitionNotesPayable`	-	USD	1 Quarter
Payment of medical clinic acquisition notes payable	`PaymentOfMedicalClinicAcquisitionNotesPayable`	$256.00K	USD	1 Quarter
Distributions to non-controlling interest shareholder	`PaymentsToMinorityShareholders`	$200.00K	USD	1 Quarter
Distributions to non-controlling interest shareholder	`PaymentsToMinorityShareholders`	-	USD	1 Quarter
Proceeds from issuance of common stock	`ProceedsFromSubscribedCommonStock`	$-2.00M	USD	1 Quarter
Proceeds from issuance of common stock	`ProceedsFromSubscribedCommonStock`	-	USD	1 Quarter
Proceeds from issuance of convertible notes payable	`ProceedsFromIssuanceOfDebt`	-	USD	1 Quarter
Proceeds from issuance of convertible notes payable	`ProceedsFromIssuanceOfDebt`	$100.00K	USD	1 Quarter
Cash payments in connection with convertible note redemption	`PaymentsForConvertibleNotesRedemption`	-	USD	1 Quarter
Cash payments in connection with convertible note redemption	`PaymentsForConvertibleNotesRedemption`	$98.25K	USD	1 Quarter
Debt and equity issuance costs	`PaymentsOfDebtIssuanceCosts`	$232.68K	USD	1 Quarter
Debt and equity issuance costs	`PaymentsOfDebtIssuanceCosts`	-	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$100.00K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$5.40M	USD	1 Quarter
NET INCREASE (DECREASE) IN CASH & CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$5.38M	USD	1 Quarter
NET INCREASE (DECREASE) IN CASH & CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-81.75K	USD	1 Quarter
CASH & CASH EQUIVALENTS, BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$6.83M	USD	Point-in-time
CASH & CASH EQUIVALENTS, BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$1.45M	USD	Point-in-time
CASH & CASH EQUIVALENTS, BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$1.18M	USD	Point-in-time
CASH & CASH EQUIVALENTS, BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$1.09M	USD	Point-in-time
CASH & CASH EQUIVALENTS, END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$6.83M	USD	Point-in-time
CASH & CASH EQUIVALENTS, END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$1.45M	USD	Point-in-time
CASH & CASH EQUIVALENTS, END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$1.18M	USD	Point-in-time
CASH & CASH EQUIVALENTS, END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$1.09M	USD	Point-in-time
Interest paid	`InterestPaid`	$84.72K	USD	1 Quarter
Interest paid	`InterestPaid`	$18.06K	USD	1 Quarter
Income taxes paid	`IncomeTaxesPaid`	$3.82K	USD	1 Quarter
Income taxes paid	`IncomeTaxesPaid`	$9.40K	USD	1 Quarter
Warrants issued in connection with convertible note issuance	`WarrantsIssuedInConnectionWithNotesPayable`	-	USD	1 Quarter
Warrants issued in connection with convertible note issuance	`WarrantsIssuedInConnectionWithNotesPayable`	$6.72K	USD	1 Quarter
Shares issuable and issued for note payable financing fees	`IssuanceOfCommonStockValueInPaymentOfFinancingCost`	-	USD	1 Quarter
Shares issuable and issued for note payable financing fees	`IssuanceOfCommonStockValueInPaymentOfFinancingCost`	$45.00K	USD	1 Quarter
NNA term loan discount	`DiscountOnTermLoan`	$1.25M	USD	1 Quarter
NNA term loan discount	`DiscountOnTermLoan`	-	USD	1 Quarter
Shares issued in connection with convertible notes redemption	`SharesIssuedInConnectionWithNotesRedemption`	$51.75K	USD	1 Quarter
Shares issued in connection with convertible notes redemption	`SharesIssuedInConnectionWithNotesRedemption`	-	USD	1 Quarter
Fair value of warrant liabilities	`FairValueOfWarrantLiabilities`	$2.35M	USD	1 Quarter
Fair value of warrant liabilities	`FairValueOfWarrantLiabilities`	-	USD	1 Quarter
NNA shares issuance discount	`DiscountOnSharesIssuance`	$1.10M	USD	1 Quarter
NNA shares issuance discount	`DiscountOnSharesIssuance`	-	USD	1 Quarter

Stockholders Equity 10 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.69M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.62M	USD	Point-in-time
Net income (loss)	`ProfitLoss`	$-710.61K	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-145.10K	USD	1 Quarter
Stock grant compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$60.19K	USD	1 Quarter
Shares issued in NNA financing	`StockIssuedDuringPeriodValueForFinancing`	$868.24K	USD	1 Quarter
8% notes share conversion	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$51.75K	USD	1 Quarter
Distributions to non-controlling interest	`MinorityInterestPeriodIncreaseDecrease`	$-200.00K	USD	1 Quarter
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.69M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.62M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.